Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Fish and Richardson
Express Scripts
Daiichi Sankyo
US Department of Justice

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020408

« Back to Dashboard

NDA 020408 describes TRUSOPT, which is a drug marketed by Merck and is included in one NDA. It is available from one supplier. Additional details are available on the TRUSOPT profile page.

The generic ingredient in TRUSOPT is dorzolamide hydrochloride. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride profile page.

Summary for 020408

Therapeutic Class:Ophthalmic Agents

Pharmacology for NDA: 020408

Mechanism of ActionCarbonic Anhydrase Inhibitors

Suppliers and Packaging for NDA: 020408

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRUSOPT dorzolamide hydrochloride SOLUTION/DROPS;OPHTHALMIC 020408 NDA Merck Sharp & Dohme Corp. 0006-3519 0006-3519-36 1 BOTTLE, DROPPER in 1 CARTON (0006-3519-36) > 10 mL in 1 BOTTLE, DROPPER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrengthEQ 2% BASE
Approval Date:Dec 9, 1994TE:ATRLD:Yes

Expired Orange Book Patents for NDA: 020408

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
MerckTRUSOPTdorzolamide hydrochlorideSOLUTION/DROPS;OPHTHALMIC020408-001Dec 9, 1994► Subscribe► Subscribe
MerckTRUSOPTdorzolamide hydrochlorideSOLUTION/DROPS;OPHTHALMIC020408-001Dec 9, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Fish and Richardson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: